Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
Official title: A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2026-09-15
Completion Date
2030-09-02
Last Updated
2026-08-24
Healthy Volunteers
No
Conditions
Interventions
BMS-986528
Specified dose on specified days
Locations (39)
Local Institution - 0068
La Jolla, California, United States
Local Institution - 0070
Loma Linda, California, United States
Local Institution - 0069
Palo Alto, California, United States
Local Institution - 0050
Aurora, Colorado, United States
Colorado Blood Cancer Institute
Denver, Colorado, United States
Local Institution - 0055
South Miami, Florida, United States
Local Institution - 0081
New York, New York, United States
Local Institution - 0079
New York, New York, United States
Local Institution - 0066
Portland, Oregon, United States
Local Institution - 0071
Philadelphia, Pennsylvania, United States
Local Institution - 0051
DeSoto, Texas, United States
Local Institution - 0048
Merksem, Flanders, Belgium
Local Institution - 0049
Leuven, Belgium
Local Institution - 0083
Aparecida de Goiânia, Goiás, Brazil
Local Institution - 0033
Porto Alegre, Rio Grande do Sul, Brazil
Local Institution - 0082
Valinhos, São Paulo, Brazil
Local Institution - 0006
Beijing, Beijing Municipality, China
Local Institution - 0080
Guangzhou, Guangdong, China
Local Institution - 0010
Zhengzhou, Henan, China
Local Institution - 0007
Nanchang, Jiangxi, China
Local Institution - 0020
Shanghai, Shanghai Municipality, China
Local Institution - 0001
Shanghai, Shanghai Municipality, China
Local Institution - 0040
München, Bavaria, Germany
Charité Research Organisation
Berlin, Germany
Local Institution - 0021
Cologne, Germany
Local Institution - 0028
Herne, Germany
St. Josef-Stift Sendenhorst
Sendenhorst, Germany
Local Institution - 0019
Rozzano, Milano, Italy
Local Institution - 0017
Roma, Italy
Local Institution - 0053
México, Mexico
Local Institution - 0023
Józefów, Masovian Voivodeship, Poland
Local Institution - 0039
A Coruña, A Coruña [La Coruña], Spain
Local Institution - 0058
Córdoba, Córdoba, Spain
Local Institution - 0037
Bern, Switzerland
Local Institution - 0027
Geneva, Switzerland
Local Institution - 0060
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
Local Institution - 0064
Kyiv, Kyiv Oblast, Ukraine
Local Institution - 0063
Poltava, Poltava Oblast, Ukraine
Local Institution - 0061
Ternopil, Ukraine